4.8 Article

Exosomal PD-L1 induces osteogenic differentiation and promotes fracture healing by acting as an immunosuppressant

Related references

Note: Only part of the references are listed.
Article Hematology

Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1 /PD-1 immunotherapy

Nikolaos Ioannou et al.

Summary: Combination therapy of PD-1/PD-L1 with avadomide enhances anti-CLL activity by inducing T-cell signaling pathways and triggering T-cell responses, illustrating the importance of blockade-based combination therapy in sensitizing CLL to checkpoint therapy.

BLOOD (2021)

Review Biotechnology & Applied Microbiology

Strategies for delivering therapeutics across the blood-brain barrier

Georg C. Terstappen et al.

Summary: The blood-brain barrier presents a challenge for delivering therapeutics to the central nervous system, particularly for biopharmaceuticals. Non-invasive approaches have been developed to help overcome this challenge, with increasing research efforts focusing on technologies to deliver therapeutics to the CNS, some of which have entered clinical testing. Developing effective strategies for crossing the blood-brain barrier is crucial for treating CNS disorders, with a particular emphasis on non-invasive methods such as receptor-mediated transcytosis and the use of neurotropic viruses, nanoparticles, and exosomes.

NATURE REVIEWS DRUG DISCOVERY (2021)

Article Engineering, Biomedical

Local administration of porcine immunomodulatory, chemotactic and angiogenic extracellular vesicles using engineered cardiac scaffolds for myocardial infarction

Marta Monguio-Tortajada et al.

Summary: The study presents a novel MSC-EV delivery approach for cardiac repair, showing significant effects in reducing immune response, promoting angiogenesis, and reducing inflammation. The research demonstrates the potential therapeutic efficacy of loading EV in engineered pericardial scaffolds for treating myocardial infarction.

BIOACTIVE MATERIALS (2021)

Review Oncology

Novel approaches to target the microenvironment of bone metastasis

Lorenz C. Hofbauer et al.

Summary: Bone metastases are a common and severe complication of advanced-stage cancers, particularly in patients with breast and prostate cancer. The interactions between cells in the bone microenvironment affect tumor cell migration, dormancy, and resistance to treatment, and interrupting these interactions can help prevent or treat skeletal metastases.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Chemistry, Multidisciplinary

Layered Double Hydroxide Modified Bone Cement Promoting Osseointegration via Multiple Osteogenic Signal Pathways

Yingjie Wang et al.

Summary: In this study, MgAl-layered double hydroxide (LDH) microsheets modified PMMA (PMMA&LDH) bone cement with superior osseointegration performance has been synthesized. The PMMA&LDH showed improved temperature and mechanical performance compared to conventional PMMA and PMMA&COL-I. In vivo experiments demonstrated the superior osteogenic ability of PMMA&LDH, suggesting its potential application in orthopedic surgeries to promote bone growth.

ACS NANO (2021)

Article Cell Biology

TGF-β1-mediated exosomal lnc-MMP2-2 increases blood-brain barrier permeability via the miRNA-1207-5p/EPB41L5 axis to promote non-small cell lung cancer brain metastasis

Dongming Wu et al.

Summary: The study revealed that TGF-beta 1-mediated exosomal lnc-MMP2-2 increases BBB permeability to promote NSCLC brain metastasis by modulating miR-1207-5p and EPB41L5. Thus, exosomal lnc-MMP2-2 may serve as a potential therapeutic target for lung cancer brain metastasis.

CELL DEATH & DISEASE (2021)

Article Biotechnology & Applied Microbiology

Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis

Yiqiang Hu et al.

Summary: This study investigated the effect of exosomes derived from pioglitazone-pretreated MSCs on diabetic wound healing. The results showed that pioglitazone-pretreated exosomes enhanced the angiogenic function of HUVECs and accelerated diabetic wound healing. The findings suggest a promising novel cell-free therapy for treating diabetic wound healing.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Review Oncology

Targeted Glucose or Glutamine Metabolic Therapy Combined With PD-1/PD-L1 Checkpoint Blockade Immunotherapy for the Treatment of Tumors - Mechanisms and Strategies

Guofeng Ma et al.

Summary: Immunotherapy, specifically PD-1/PD-L1 checkpoint blockade therapy, has revolutionized tumor treatment, but many patients do not respond. The metabolic interactions between tumors, immune cells, and the tumor microenvironment play a key role in tumor immune escape. Targeting tumor metabolism in combination with immunotherapy may enhance therapeutic effects, but the specific metabolic pathways targeted can vary in different tumors.

FRONTIERS IN ONCOLOGY (2021)

Article Orthopedics

Management of Vertical Sternal Fracture Nonunion in Elite-Level Athletes

Andrea Bardos et al.

Summary: This study described the management and surgical treatment of elite-level athletes who had symptomatic nonunions of a vertical sternal fracture, resulting in significant improvements postoperatively. Four out of five patients were able to return to their pre-injury sport level.

ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE (2021)

Article Engineering, Biomedical

Exosome-functionalized polyetheretherketone-based implant with immunomodulatory property for enhancing osseointegration

Lei Fan et al.

Summary: A BMSC-derived Exos-functionalized implant was developed to accelerate bone integration through immunoregulation, which improved the biocompatibilities of SPEEK and promoted macrophage polarization, osteogenic differentiation, and new bone formation.

BIOACTIVE MATERIALS (2021)

Review Biochemistry & Molecular Biology

New insights into the important roles of tumor cell-intrinsic PD-1

Hongmei Zheng et al.

Summary: PD-1 and its ligands PD-L1/PD-L2 play important roles in tumor immune evasion, while PD-1 could also activate signaling pathways in tumor cells to promote tumor growth. PD-1 is expressed in certain tumors and is associated with patient prognosis.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Article Cell & Tissue Engineering

Targeting angiogenesis for fracture nonunion treatment in inflammatory disease

Cuicui Wang et al.

Summary: This study established a unique nonunion model with high clinical relevance using rheumatoid arthritis (RA) mice, demonstrating that the angiogenesis defect under inflammatory conditions was mainly caused by downregulation of SPP1 and CXCL12. By developing a scaffold loaded with SPP1 and CXCL12, it significantly promoted angiogenesis and fracture repair in mice with inflammation.

BONE RESEARCH (2021)

Article Cell Biology

IL-10 induces MC3T3-E1 cells differentiation towards osteoblastic fate in murine model

Yuan Xiong et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

Article Cell Biology

Exosomal PD-L1 functions as an immunosuppressant to promote wound healing

Dandan Su et al.

JOURNAL OF EXTRACELLULAR VESICLES (2020)

Article Biotechnology & Applied Microbiology

Saliva exosomes-derived UBE2O mRNA promotes angiogenesis in cutaneous wounds by targeting SMAD6

Bobin Mi et al.

JOURNAL OF NANOBIOTECHNOLOGY (2020)

Article Multidisciplinary Sciences

Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti-PD-1/PD-L1 immunotherapy

Muhammad Zaeem Noman et al.

SCIENCE ADVANCES (2020)

Editorial Material Cardiac & Cardiovascular Systems

Exosome-derived microRNAs improve cardiac function

Andrew Robson

NATURE REVIEWS CARDIOLOGY (2020)